Transcriptional response of polycomb group genes to status epilepticus in mice is modified by prior exposure to epileptic preconditioning

Frontiers in Neurology

Volumn 6, Issue MAR, 2015, Pages

  Reynolds, James P ^a   Miller Delaney, Suzanne F C ^a   Jimenez Mateos, Eva M ^a   Sano, Takanori ^a,b   McKiernan, Ross C ^a   Simon, Roger P ^c   Henshall, David C ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

Epileptic tolerance; Hippocampal sclerosis; Neuroprotection; Polycomb; Temporal lobe epilepsy

Indexed keywords

BMI1 PROTEIN; POLYCOMB REPRESSIVE COMPLEX 2; SIRTUIN 1; TRANSCRIPTION FACTOR YY1;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BMI1 GENE; CONTROLLED STUDY; DOWN REGULATION; EPILEPTIC STATE; EZH1 GENE; EZH2 GENE; GENE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HIPPOCAMPUS; MALE; MOUSE; NONHUMAN; PRC1 GENE; PRC2 GENE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RING1A GENE; RING1B GENE; SIRT1 GENE; SUZ12 GENE; TRANSCRIPTION REGULATION; YY1 GENE; YY2 GENE;

EID: 84926354715     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2015.00046     Document Type: Article

References (65)

1. Meaney MJ, Ferguson-Smith AC. Epigenetic regulation of the neural transcriptome: the meaning of the marks. Nat Neurosci (2010) 13:1313-8. doi:10.1038/nn1110-1313
2. Miller CA, Sweatt JD. Covalent modification of DNA regulates memory formation. Neuron (2007) 53:857-69. doi:10.1016/j.neuron.2007.02.022
3. Maze I, Noh K-M, Allis CD. Histone regulation in the CNS: basic principles of epigenetic plasticity. Neuropsychopharmacology (2013) 38:3-22. doi:10.1038/npp.2012.124
4. Urdinguio RG, Sanchez-Mut JV, Esteller M. Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurol (2009) 8:1056-72. doi:10.1016/S1474-4422(09)70262-5
5. Iraola-Guzmán S, Estivill X, Rabionet R. DNA methylation in neurodegenerative disorders: a missing link between genome and environment? Clin Genet (2011) 80:1-14. doi:10.1111/j.1399-0004.2011.01673.x
6. Kobow K, Blümcke I. The methylation hypothesis: do epigenetic chromatin modifications play a role in epileptogenesis? Epilepsia (2011) 52(Suppl 4):15-9. doi:10.1111/j.1528-1167.2011.03145.x
7. Zhu Q, Wang L, Zhang Y, Zhao F-H, Luo J, Xiao X, et al. Increased expression of DNA methyltransferase 1 and 3a in human temporal lobe epilepsy. J Mol Neurosci (2012) 46:420-6. doi:10.1007/s12031-011-9602-7
8. Jin B, Tao Q, Peng J, Soo HM, Wu W, Ying J, et al. DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function. Hum Mol Genet (2008) 17:690-709. doi:10.1093/hmg/ddm341
9. Huang Y, Doherty JJ, Dingledine R. Altered histone acetylation at glutamate receptor 2 and brain-derived neurotrophic factor genes is an early event triggered by status epilepticus. J Neurosci (2002) 22:8422-8.
10. Tsankova NM, Kumar A, Nestler EJ. Histone modifications at gene promoter regions in rat hippocampus after acute and chronic electroconvulsive seizures. J Neurosci (2004) 24:5603-10. doi:10.1523/JNEUROSCI.0589-04.2004
11. Park HG, Yu HS, Park S, Ahn YM, Kim YS, Kim SH. Repeated treatment with electroconvulsive seizures induces HDAC2 expression and down-regulation of NMDA receptor-related genes through histone deacetylation in the rat frontal cortex. Int J Neuropsychopharmacol (2014) 17:1487-500. doi:10.1017/S1461145714000248
12. Huang Y, Zhao F, Wang L, Yin H, Zhou C, Wang X. Increased expression of histone deacetylases 2 in temporal lobe epilepsy: a study of epileptic patients and rat models. Synapse (2012) 66:151-9. doi:10.1002/syn.20995
13. Roopra A, Dingledine R, Hsieh J. Epigenetics and epilepsy. Epilepsia (2012) 53(Suppl 9):2-10. doi:10.1111/epi.12030
14. Goldberg EM, Coulter DA. Mechanisms of epileptogenesis: a convergence on neural circuit dysfunction. Nat Rev Neurosci (2013) 14:337-49. doi:10.1038/nrn3482
15. Schwartz YB, Pirrotta V. Polycomb silencing mechanisms and the management of genomic programmes. Nat Rev Genet (2007) 8:9-22. doi:10.1038/nrg1981
16. Lewis EB. A gene complex controlling segmentation in Drosophila. Nature (1978) 276:565-70. doi:10.1038/276565a0
17. Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, Tempst P, et al. Role of histone H3 lysine 27 methylation in polycomb-group silencing. Science (2002) 298:1039-43. doi:10.1126/science.1076997
18. Simon JA, Kingston RE. Mechanisms of polycomb gene silencing: knowns and unknowns. Nat Rev Mol Cell Biol (2009) 10:697-708. doi:10.1038/nrm2763
19. Mills AA. Throwing the cancer switch: reciprocal roles of polycomb and trithorax proteins. Nat Rev Cancer (2010) 10:669-82. doi:10.1038/nrc2931
20. Ma DK, Marchetto MC, Guo JU, Ming G-L, Gage FH, Song H. Epigenetic choreographers of neurogenesis in the adult mammalian brain. Nat Neurosci (2010) 13:1338-44. doi:10.1038/nn.2672
21. Pereira JD, Sansom SN, Smith J, Dobenecker M-W, Tarakhovsky A, Livesey FJ. Ezh2, the histone methyltransferase of PRC2, regulates the balance between self-renewal and differentiation in the cerebral cortex. Proc Natl Acad Sci U S A (2010) 107:15957-62. doi:10.1073/pnas.1002530107
22. Zhang J, Ji F, Liu Y, Lei X, Li H, Ji G, et al. Ezh2 regulates adult hippocampal neurogenesis and memory. J Neurosci (2014) 34:5184-99. doi:10.1523/JNEUROSCI.4129-13.2014
23. Di Meglio T, Kratochwil CF, Vilain N, Loche A, Vitobello A, Yonehara K, et al. Ezh2 orchestrates topographic migration and connectivity of mouse precerebellar neurons. Science (2013) 339:204-7. doi:10.1126/science.1229326
24. Qi C, Liu S, Qin R, Zhang Y, Wang G, Shang Y, et al. Coordinated regulation of dendrite arborization by epigenetic factors CDYL and EZH2. J Neurosci (2014) 34:4494-508. doi:10.1523/JNEUROSCI.3647-13.2014
25. Södersten E, Feyder M, Lerdrup M, Gomes A-L, Kryh H, Spigolon G, et al. Dopamine signaling leads to loss of polycomb repression and aberrant gene activation in experimental parkinsonism. PLoS Genet (2014) 10:e1004574. doi:10.1371/journal.pgen.1004574
26. Liu K, Ding L, Li Y, Yang H, Zhao C, Lei Y, et al. Neuronal necrosis is regulated by a conserved chromatin-modifying cascade. Proc Natl Acad Sci U S A (2014) 101:13960-5. doi:10.1073/pnas.1413644111
27. Stapels M, Piper C, Yang T, Li M, Stowell C, Xiong ZG, et al. Polycomb group proteins as epigenetic mediators of neuroprotection in ischemic tolerance. Sci Signal (2010) 3:ra15. doi:10.1126/scisignal.2000502
28. Jimenez-Mateos EM, Henshall DC. Seizure preconditioning and epileptic tolerance: models and mechanisms. Int J Physiol Pathophysiol Pharmacol (2009) 1:180-91.
29. Jimenez-Mateos EM, Hatazaki S, Johnson MB, Bellver-Estelles C, Mouri G, Bonner C, et al. Hippocampal transcriptome after status epilepticus in mice rendered seizure damage-tolerant by epileptic preconditioning features suppressed calcium and neuronal excitability pathways. Neurobiol Dis (2008) 32:442-53. doi:10.1016/j.nbd.2008.08.008
30. Gidday JM. Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci (2006) 7:437-48. doi:10.1038/nrn1927
31. Blondeau N, Widmann C, Lazdunski M, Heurteaux C. Activation of the nuclear factor-kappaB is a key event in brain tolerance. J Neurosci (2001) 21:4668-77.
32. Yoneda Y, Ogita K. Rapid and selective enhancement of DNA binding activity of the transcription factor AP1 by systemic administration of N-methyl-D-aspartate in murine hippocampus. Neurochem Int (1994) 25:263-71. doi:10.1016/0197-0186(94)90070-1
33. Miller-Delaney SFC, Das S, Sano T, Jimenez-Mateos EM, Bryan K, Buckley PG, et al. Differential DNA methylation patterns define status epilepticus and epileptic tolerance. J Neurosci (2012) 32:1577-88. doi:10.1523/JNEUROSCI.5180-11.2012
34. Mouri G, Jimenez-Mateos E, Engel T, Dunleavy M, Hatazaki S, Paucard A, et al. Unilateral hippocampal CA3-predominant damage and short latency epileptogenesis after intra-amygdala microinjection of kainic acid in mice. Brain Res (2008) 1213:140-51. doi:10.1016/j.brainres.2008.03.061
35. Lein ES, Zhao X, Gage FH. Defining a molecular atlas of the hippocampus using DNA microarrays and high-throughput in situ hybridization. J Neurosci (2004) 24:3879-89. doi:10.1523/JNEUROSCI.4710-03.2004
36. Kim SY, Levenson JM, Korsmeyer S, Sweatt JD, Schumacher A. Developmental regulation of Eed complex composition governs a switch in global histone modification in brain. J Biol Chem (2007) 282:9962-72. doi:10.1074/jbc.M608722200
37. Abdouh M, Chatoo W, El Hajjar J, David J, Ferreira J, Bernier G. Bmi1 is down-regulated in the aging brain and displays antioxidant and protective activities in neurons. PLoS One (2012) 7:e31870. doi:10.1371/journal.pone.0031870
38. Vandamme J, Völkel P, Rosnoblet C, Le Faou P, Angrand P-O. Interaction proteomics analysis of polycomb proteins defines distinct PRC1 complexes in mammalian cells. Mol Cell Proteomics (2011) 10:M110.002642. doi:10.1074/mcp.M110.002642
39. Becker AJ, Chen J, Zien A, Sochivko D, Normann S, Schramm J, et al. Correlated stage- and subfield-associated hippocampal gene expression patterns in experimental and human temporal lobe epilepsy. Eur J Neurosci (2003) 18:2792-802. doi:10.1111/j.1460-9568.2003.02993.x
40. Gorter JA, van Vliet EA, Aronica E, Breit T, Rauwerda H, Lopes da Silva FH, et al. Potential new antiepileptogenic targets indicated by microarray analysis in a rat model for temporal lobe epilepsy. J Neurosci (2006) 26:11083-110. doi:10.1523/JNEUROSCI.2766-06.2006
41. Laurén HB, Lopez-Picon FR, Brandt AM, Rios-Rojas CJ, Holopainen IE. Transcriptome analysis of the hippocampal CA1 pyramidal cell region after kainic acid-induced status epilepticus in juvenile rats. PLoS One (2010) 5:e10733. doi:10.1371/journal.pone.0010733
42. Elliott RC, Miles MF, Lowenstein DH. Overlapping microarray profiles of dentate gyrus gene expression during development- and epilepsy-associated neurogenesis and axon outgrowth. J Neurosci (2003) 23:2218-27.
43. Buira SP, Dentesano G, Albasanz JL, Moreno J, Martín M, Ferrer I, et al. DNA methylation and Yin Yang-1 repress adenosine A2A receptor levels in human brain. J Neurochem (2010) 115:283-95. doi:10.1111/j.1471-4159.2010.06928.x
44. Korhonen P, Kyrylenko S, Suuronen T, Salminen A. Changes in DNA binding pattern of transcription factor YY1 in neuronal degeneration. Neurosci Lett (2005) 377:121-4. doi:10.1016/j.neulet.2004.11.085
45. Rylski M, Amborska R, Zybura K, Mioduszewska B, Michaluk P, Jaworski J, et al. Yin Yang 1 is a critical repressor of matrix metalloproteinase-9 expression in brain neurons. J Biol Chem (2008) 283:35140-53. doi:10.1074/jbc.M804540200
46. Ohtomo T, Kanamatsu T, Fujita M, Takagi M, Yamada J. Sustained downregulation of YY1-associated protein-related protein gene expression in rat hippocampus induced by repeated electroconvulsive shock. Biol Pharm Bull (2011) 34:249-52. doi:10.1248/bpb.34.249
47. Pallàs M, Pizarro JG, Gutierrez-Cuesta J, Crespo-Biel N, Alvira D, Tajes M, et al. Modulation of SIRT1 expression in different neurodegenerative models and human pathologies. Neuroscience (2008) 154:1388-97. doi:10.1016/j.neuroscience.2008.04.065
48. Chung S, Kim HJ, Yoon IS, Kim HJ, Choi SH, Kim YS, et al. Electroconvulsive shock increases SIRT1 immunoreactivity in the mouse hippocampus and hypothalamus. J ECT (2013) 29:93-100. doi:10.1097/YCT.0b013e31827659f7
49. Wang SJ, Zhao XH, Chen W, Bo N, Wang XJ, Chi ZF, et al. Sirtuin 1 activation enhances the PGC-1α/mitochondrial antioxidant system pathway in status epilepticus. Mol Med Rep (2015) 11:521-6. doi:10.3892/mmr.2014.2724
50. Calao M, Sekyere EO, Cui HJ, Cheung BB, Thomas WD, Keating J, et al. Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation. Oncogene (2013) 32:3616-26. doi:10.1038/onc.2012.368
51. Su W-J, Fang J-S, Cheng F, Liu C, Zhou F, Zhang J. RNF2/Ring1b negatively regulates p53 expression in selective cancer cell types to promote tumor development. Proc Natl Acad Sci U S A (2013) 110:1720-5. doi:10.1073/pnas.1211604110
52. Gu M, Shen L, Bai L, Gao J, Marshall C, Wu T, et al. Heterozygous knockout of the Bmi-1 gene causes an early onset of phenotypes associated with brain aging. Age (2014) 36:129-39. doi:10.1007/s11357-013-9552-9
53. Yamakuchi M, Lowenstein CJ. MiR-34, SIRT1 and p53: the feedback loop. Cell Cycle (2009) 8:712-5. doi:10.4161/cc.8.5.7753
54. Wu Z, Lee ST, Qiao Y, Li Z, Lee PL, Lee YJ, et al. Polycomb protein EZH2 regulates cancer cell fate decision in response to DNA damage. Cell Death Differ (2011) 18:1771-9. doi:10.1038/cdd.2011.48
55. Dietrich N, Lerdrup M, Landt E, Agrawal-Singh S, Bak M, Tommerup N, et al. REST-mediated recruitment of polycomb repressor complexes in mammalian cells. PLoS Genet (2012) 8:e1002494. doi:10.1371/journal.pgen.1002494
56. Arnold P, Schöler A, Pachkov M, Balwierz PJ, Jørgensen H, Stadler MB, et al. Modeling of epigenome dynamics identifies transcription factors that mediate polycomb targeting. Genome Res (2013) 23:60-73. doi:10.1101/gr.142661.112
57. Parent JM, Kron MM. Neurogenesis and epilepsy. 4th ed. In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV, editors. Jasper's Basic Mechanisms of the Epilepsies [Internet]. Bethesda, MD: National Center for Biotechnology Information (US) (2012). p. 506-13.
58. Ku M, Koche RP, Rheinbay E, Mendenhall EM, Endoh M, Mikkelsen TS, et al. Genome wide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains. PLoS Genet (2008) 4:e1000242. doi:10.1371/journal.pgen.1000242
59. Schoeftner S, Sengupta AK, Kubicek S, Mechtler K, Spahn L, Koseki H, et al. Recruitment of PRC1 function at the initiation of X inactivation independent of PRC2 and silencing. EMBO J (2006) 25:3110-22. doi:10.1038/sj.emboj.7601187
60. Ren X, Kerppola TK. REST interacts with Cbx proteins and regulates polycomb repressive complex 1 occupancy at RE1 elements. Mol Cell Biol (2011) 31:2100-10. doi:10.1128/MCB.05088-11
61. Pietersen AM, Horlings HM, Hauptmann M, Langerød A, Ajouaou A, Cornelissen-Steijger P, et al. EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer. Breast Cancer Res (2008) 10:R109. doi:10.1186/bcr2214
62. Margueron R, Li G, Sarma K, Blais A, Zavadil J, Woodcock CL, et al. Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms. Mol Cell (2008) 32:503-18. doi:10.1016/j.molcel.2008.11.004
63. Shen X, Liu Y, Hsu Y-J, Fujiwara Y, Kim J, Mao X, et al. EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency. Mol Cell (2008) 32:491-502. doi:10.1016/j.molcel.2008.10.016
64. Ezhkova E, Lien W-H, Stokes N, Pasolli HA, Silva JM, Fuchs E. EZH1 and EZH2 cogovern histone H3K27 trimethylation and are essential for hair follicle homeostasis and wound repair. Genes Dev (2011) 25:485-98. doi:10.1101/gad.2019811
65. Margueron R, Reinberg D. The polycomb complex PRC2 and its mark in life. Nature (2011) 469:343-9. doi:10.1038/nature09784